glp-1 and high blood pressure drugs improve liver heart health A study of 42,000 adults

Metabolites 12 (2), 183 (2022) M

pIC 50 values were calculated from heterologous competition binding assays using 125 I-Ex4(9-39) tracer

From a nutrition support standpoint, the shift back to branded medications also means the patient population becomes more defined and trackable, which is actually an opportunity for better clinical integration of dietary protocols alongside pharmacotherapy

doi: 10.1016/S0140-6736(18)32261-X 42 GersteinHCColhounHMDagenaisGRDiazRLakshmananMPaisPet al

3 The FDA approval of Wegovy pill is based on the results from the OASIS 4 phase 3 clinical trial, which was a 64-week medical study that included 307 adults with obesity or overweight with one or more weight-related comorbidities, without diabetes

Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes